Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies

Agnès Poirier, Sara Belli, Christoph Funk, Michael B. Otteneder, Renée Portmann, Katja Heinig, Eric Prinssen, Stanley E. Lazic, Craig R. Rayner, Gerhard Hoffmann, Thomas Singer, David E. Smith and Franz Schuler
Drug Metabolism and Disposition August 2012, 40 (8) 1556-1565; DOI: https://doi.org/10.1124/dmd.112.044990
Agnès Poirier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Belli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Funk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael B. Otteneder
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renée Portmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katja Heinig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Prinssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley E. Lazic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig R. Rayner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Hoffmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Singer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franz Schuler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 40 no. 8 1556-1565
DOI 
https://doi.org/10.1124/dmd.112.044990
PubMed 
22584254

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 13, 2012
  • Accepted May 14, 2012
  • Published online July 17, 2012.

Article Versions

  • Earlier version (May 14, 2012 - 11:59).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Agnès Poirier,
  2. Sara Belli,
  3. Christoph Funk,
  4. Michael B. Otteneder,
  5. Renée Portmann,
  6. Katja Heinig,
  7. Eric Prinssen,
  8. Stanley E. Lazic,
  9. Craig R. Rayner,
  10. Gerhard Hoffmann,
  11. Thomas Singer,
  12. David E. Smith and
  13. Franz Schuler
  1. Non-Clinical Safety (A.P., S.B., C.F., M.B.O., R.P., K.H., G.H., T.S., F.S.), CNS Discovery (E.P.), and Bioinformatics and Exploratory Data Analysis (S.E.L.), F. Hoffmann-La Roche Ltd., Basel, Switzerland; Roche Products Pty Ltd., Melbourne, Australia (C.R.R.); Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia (C.R.R.); and Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan (D.E.S.)
  1. Address correspondence to:
    Franz Schuler, F. Hoffmann-La Roche Ltd., B70/R144, Grenzacherstrasse 124, CH-4070, Basel, Switzerland. E-mail: franz.schuler{at}roche.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 20172238
Sep 20175123
Oct 20172134
Nov 201712916
Dec 20170315
Jan 20180226
Feb 201831710
Mar 201822415
Apr 201813221
May 201801418
Jun 201801614
Jul 2018062
Aug 20180176
Sep 201802310
Oct 201832012
Nov 20181105
Dec 20181825
Jan 20191502
Feb 20192704
Mar 201921212
Apr 20191207
May 2019900
Jun 2019805
Jul 20191005
Aug 20191301
Oct 20191516
Nov 20192100
Dec 20192605
Jan 20201635
Feb 20201110
Mar 20201501
May 20202501
Jun 20201052
Jul 20201411
Aug 2020902
Sep 20201900
Oct 20201414
Nov 20201512
Dec 20201053
Jan 20211516
Feb 20213047
Mar 20211230
Apr 20211810
May 20211210
Jun 20211575
Jul 2021511
Aug 2021714
Sep 20211611
Oct 2021811
Nov 20212615
Dec 20211823
Jan 2022711
Feb 2022411
Mar 20221932
Apr 20221135
May 2022715
Jun 20222410
Jul 20228110
Aug 2022500

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (8)
Drug Metabolism and Disposition
Vol. 40, Issue 8
1 Aug 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Role of the Intestinal Peptide Transporter PEPT1 in Oseltamivir Absorption: In Vitro and In Vivo Studies
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ROLE OF PEPT1 IN OSELTAMIVIR ABSORPTION

Agnès Poirier, Sara Belli, Christoph Funk, Michael B. Otteneder, Renée Portmann, Katja Heinig, Eric Prinssen, Stanley E. Lazic, Craig R. Rayner, Gerhard Hoffmann, Thomas Singer, David E. Smith and Franz Schuler
Drug Metabolism and Disposition August 1, 2012, 40 (8) 1556-1565; DOI: https://doi.org/10.1124/dmd.112.044990

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ROLE OF PEPT1 IN OSELTAMIVIR ABSORPTION

Agnès Poirier, Sara Belli, Christoph Funk, Michael B. Otteneder, Renée Portmann, Katja Heinig, Eric Prinssen, Stanley E. Lazic, Craig R. Rayner, Gerhard Hoffmann, Thomas Singer, David E. Smith and Franz Schuler
Drug Metabolism and Disposition August 1, 2012, 40 (8) 1556-1565; DOI: https://doi.org/10.1124/dmd.112.044990
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro-In Vivo Extrapolation Using Empirical Scaling
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics